PPARGC1A and inborn mitochondrial metabolism disorder: Due to its role in mitochondrial biogenesis and functions related to oxidative phosphorylation (OXPHOS) capacity and oxidative stress (14), PGC-1α is considered to be a therapeutic target for mitochondrial diseases including MELAS.